Recent scientific studies have found that using Tylenol (or generic acetaminophen) during pregnancy disrupts fetal development and may increase the risk of having a baby with autism. This new research has sparked a growing wave of product liability lawsuits by parents of children born with autism after acetaminophen use during pregnancy.
Since the Tylenol autism lawsuits were consolidated into a class action MDL last year, MDL Judge Denise Cote has progressed the litigation forward at a very rapid pace. As of September 2023, the initial round of Daubert briefs challenging the expert witnesses on both sides have been submitted. The outcome of the Daubert challenges will determine the future of this litigation. If Judge Cote rules that the opinions of the plaintiffs’ experts are not admissible, it will effectively end the MDL. If, however, she denies the motions to exclude the plaintiffs’ experts, we could actually see a major global settlement next year.
In this post, our lawyers estimate what the possible settlement amounts of a Tylenol autism lawsuit might be.
